openPR Logo
Press release

A Deep Dive into Endocrinology Drugs Market 2025: Key Drivers, Growth Factors, and Projections 2025-2034

03-28-2025 11:45 AM CET | Health & Medicine

Press release from: The Business Research Company

Endocrinology Drugs

Endocrinology Drugs

What industry-specific factors are fueling the growth of the endocrinology drugs market?
The escalating incidence of endocrine disorders is anticipated to stimulate the expansion of the endocrinology drugs market in the future. Endocrine disorders are conditions that affect the endocrine system, leading to irregularities in hormone production or regulation, subsequently affecting normal bodily functions. The increased incidence of endocrine disorders can be credited to various factors such as changes in lifestyle, an aging demographic, and enhanced diagnostics, which have collectively resulted in greater recognition and prevalence of these conditions. Endocrinology medications help to control endocrine diseases by balancing hormone levels, addressing glandular anomalies, and reinstating hormonal equilibrium to alleviate symptoms and enhance overall health outcomes. For example, in May 2023, as per the National Library of Medicine, a medicinal library based in the United States, approximately 13 million individuals or 4.78% of the US population is suffering from undisclosed endocrine disorders. Among them, thyroid disease is identified as one of the most common endocrine disorders, contributing to around 30% to 40% of patients undergoing treatment in endocrine practices. Consequently, the escalating incidence of endocrine diseases propels growth in the endocrinology drugs market.

Get Your Endocrinology Drugs Market Report Here:
https://www.thebusinessresearchcompany.com/report/endocrinology-drugs-global-market-report

What Is the projected market size and growth rate for the endocrinology drugs market?
Over the recent past, there has been robust growth in the market size of endocrinology drugs. This market is projected to expand from $33.26 billion in 2024 to $36.21 billion in 2025, with a compound annual growth rate (CAGR) pegged at 8.86%. Various factors have contributed to the historic rise, including the global surge in diabetes cases, government initiatives aimed boosting the sector, enhanced healthcare spending, rising instances of adrenal gland disorders, an increased demand for insulin analogs, and the growth of the endocrinologist fraternity.

The market size for endocrinology drugs is predicted to experience robust expansion in the upcoming years, reaching a value of $50.37 billion in 2029, with a compound annual growth rate (CAGR) of 8.60%. This projected growth over the forecast period is due to factors such as the rising number of diabetes patients, increasing cases of endocrine disorders, a higher incidence of hormonal imbalances among teenagers, and escalating rates of obesity. Key trends anticipated over the forecast period encompass technological innovation, the embrace of sophisticated drug delivery systems, incorporation of digital health solutions, precision medicine, and combination therapies.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20769&type=smp

What new trends are reshaping the endocrinology drugs market and its opportunities?
Leading businesses in the endocrinology drugs market are concentrating their efforts on creating innovative solutions such as ready-to-use vials to enhance the process of administering medication. These vials are pre-filled and pre-dosed medication vessels that eliminate the need for prior preparation or reconstitution. For example, in December 2022, UK-based Hikma Pharmaceuticals plc unveiled a Levothyroxine sodium injection in ready-to-use vials at a dose concentration of 100 mcg/mL. This formulation eradicates the requirement for reconstitution and minimises preparation error possibilities, thereby boosting patient safety. This new product ensures exact and consistent dosage, a vital component in treating disorders like hypothyroidism and myxedema coma. Additionally, these ready-to-use vials increase healthcare providers' efficiency by saving time and confirming accurate administration in emergency healthcare scenarios.

What major market segments define the scope and growth of the endocrinology drugs market?
The endocrinology drugs market covered in this report is segmented -

1) By Indication: Hyperthyroidism, Hypothyroidism, Diabetes, Polycystic Ovarian Syndrome, Growth Hormone Disorders, Pituitary Gland Disorders, Other Indications
2) By Therapy Area: Diabetes Drugs, Thyroid Hormone Disorder Drugs, Human Growth Hormone, Testosterone Replacement Therapy, Others Therapy Areas
3) By Distribution Channel: Hospital pharmacies, Online Pharmacies, Retail pharmacies
4) By End User: Hospitals, Ambulatory Surgical Centers, Others End Users

Subsegments:
1) By Hyperthyroidism: Antithyroid Medications, Radioactive Iodine Therapy, Beta Blockers
2) By Hypothyroidism: Levothyroxine-based Medications, Liothyronine-based Medications, Combination Hormonal Therapies
3) By Diabetes: Insulin Therapies, Oral Antidiabetic Drugs (OADs), GLP-1 Receptor Agonists, SGLT-2 Inhibitors, DPP-4 Inhibitors
4) By Polycystic Ovarian Syndrome (PCOS): Oral Contraceptives, Metformin, Clomiphene Citrate, Anti-Androgens
5) By Growth Hormone Disorders: Recombinant Human Growth Hormone (rhGH), Growth Hormone Secretagogues, Growth Hormone Receptor Antagonists
6) By Pituitary Gland Disorders: Somatostatin Analogs, Gonadotropins, Dopamine Agonists
7) By Other Indications: Adrenal Gland Disorders, Osteoporosis, Parathyroid Disorders, Male Hormonal Imbalances

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20769

Which region dominates the endocrinology drugs market?
North America was the largest region in the endocrinology drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the endocrinology drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which key market leaders are driving the endocrinology drugs industry growth?
Major companies operating in the endocrinology drugs market are Johnson & Johnson Inc., Merck & Co. Inc., AbbVie Inc., Bayer Aktiengesellschaft, Novartis International AG, Sanofi S.A., AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Biocon Limited, Boehringer Ingelheim International GmbH, Mylan N.V., Sandoz International GmbH, Ipsen Pharma, Ferring Pharmaceuticals Inc., Endocrine Pharma Private Limited

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=20769&type=smp

What Is Covered In The Endocrinology Drugs Global Market Report?

•Market Size Forecast: Examine the endocrinology drugs market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the endocrinology drugs market for a structured understanding.
•Key Players Overview: Analyze major players in the endocrinology drugs market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the endocrinology drugs market.
•Segment Contributions: Evaluate how different segments drive overall growth in the endocrinology drugs market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the endocrinology drugs market.
•Industry Challenges: Identify potential risks and obstacles affecting the endocrinology drugs market.
•Competitive Landscape: Review strategic developments in the endocrinology drugs market, including expansions, agreements, and new product launches.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release A Deep Dive into Endocrinology Drugs Market 2025: Key Drivers, Growth Factors, and Projections 2025-2034 here

News-ID: 3944902 • Views:

More Releases from The Business Research Company

Global Dermal Regeneration Market Expansion at 8.9% CAGR, Valued at $2.52 Billion by 2029
Global Dermal Regeneration Market Expansion at 8.9% CAGR, Valued at $2.52 Billio …
"Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide. What Are the Dermal Regeneration Market Size Forecast for 2025? In recent years, the market size of dermal regeneration has significantly expanded. Its growth is set to continue, moving from a market value of $1.64 billion in 2024, surging to $1.79 billion in 2025, indicating a Compound Annual Growth Rate
Dental Emergency Kit Market Expansion Outlook: $1.74 Billion in 2029
Dental Emergency Kit Market Expansion Outlook: $1.74 Billion in 2029
"Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments. What Is the Projected CAGR for the Dental Emergency Kit Market from 2024 to 2025? In recent times, the dental emergency kit market has seen significant growth. Projected growth rates suggest an increase from $1.18 billion in 2024 to $1.28 billion in 2025, manifesting a compound annual growth rate (CAGR) of 8.2%.
Cryopreservation Equipment Industry Growth Outlook: 15.4% CAGR and $19.55 Billion by 2029
Cryopreservation Equipment Industry Growth Outlook: 15.4% CAGR and $19.55 Billio …
"Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments. What Is the Long-Term Growth Forecast for the Cryopreservation Equipment Market Size 2025? The expansion of the cryopreservation equipment market has been significant in recent years. The market which is expected to escalate from $9.52 billion in 2024 to $11.01 billion in 2025, will do so with a compound annual growth rate
Connected Wearable Patches Industry to Achieve $10.78 Billion Growth by 2029
Connected Wearable Patches Industry to Achieve $10.78 Billion Growth by 2029
"Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments. How Will the Connected Wearable Patches Market Grow by 2025 in Terms of Size and Growth? The market size for connected wearable patches has seen significant expansion in the most recent years. With an expected rise from $5.62 billion in 2024 to $6.42 billion in 2025, representing a compound annual growth rate

All 5 Releases


More Releases for Drugs

Generic Drugs Market Application Anti-Infective Drugs, Anti-Arthritis Drugs, Ant …
Generic drugs are the medications that are developed to be similar to a medicine that is already commercially available in the market with a brand name. The generic drug is similar to the medicine available in terms of dosage, safety and strength, mode of administration, quality and intended use. Due to the similarities, generic drugs are capable of treating various diseases. Generic drugs are most cost effective than the branded
Cytotoxic Drugs Market Growing Demand for Antimetabolite Drugs
According to Precision Business Insights (PBI), the latest report, the cytotoxic drugs market is expected to be valued at USD 15,927.2 million in 2022 and is poised to grow at a significant CAGR of 2.2% over 2022-2028. The primary drivers of the expansion of the global cytotoxic drugs market include the increasing prevalence of cancer diseases, the increasing use and approval of cytotoxic drugs, and the increasing consumption of alcohol
Global Antithrombotic Drugs Market | Global Antithrombotic Drugs Industry | Glob …
Antithrombotic drugs are special drugs that help to prevent the formation of thrombus or clot. These drugs are used to reduce the formation of blood clots by reducing the capability of body to form a blood clot. Antithrombotic drugs act by preventing the production of vitamin K in the liver. Anticoagulant, antiplatelet, and thrombolytic agents are different types of antithrombotic agents that act by different clotting processes. Arterial & venous
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication
Hepatitis Drugs Market by Therapeutics, Diagnostics, Patient, Drugs Policy
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market. Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest
Epilepsy Drugs Market by Country, Drugs, Company & Forecast
For More Information: https://renub-research.blogspot.com/2019/04/the-factors-that-are-driving-global.html Epilepsy is a chronic disease in which patient’s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types - generalized seizures and focal or partial seizures. Generalized seizures affect the whole brain whereas focal or partial seizures affect just one part of the brain. Global epilepsy drugs market is expected to cross US$